packageDorzagliatin

dorzagliatin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Dorzagliatin is an investigational blood glucose-lowering drug studied for diabetes. It is not yet an approved medicine and has no marketing authorisation in the European Union.

Summary written by glm-5.3-flash from Wikidata Q76754209 and the WHO ATC classification; not checked by a person.

name:dorzagliatin
ATC codes:A10BX18
DrugBank:DB15123
PubChem CID:57920094
Wikidata:Q76754209
formula:C22H27ClN4O5
molar mass:462.931 g/mol (PubChem CID 57920094)
logP:1.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown